Login / Signup

Pregnancy and breastfeeding in hidradenitis suppurativa: A review of medication safety.

Erin K CollierJustine R SeivrightVivian Y ShiJennifer L Hsiao
Published in: Dermatologic therapy (2020)
Hidradenitis suppurativa (HS) is a chronic inflammatory disease that disproportionately affects women of childbearing age. Pregnancy influences HS severity for many women, thus diligent continued management throughout pregnancy and postpartum may be required. Herein, we provide an updated review of pregnancy and lactation safety data for HS medications, including topical antiseptic washes, topical and systemic antibiotics, biologic and nonbiologic immunomodulators, immunosuppressants, adjunct medical therapies, and pain medications, to help guide risk-benefit discussions between providers and HS patients.
Keyphrases